Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-30

FDA Approved: QUETIAPINE FUMARATE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for a generic quetiapine fumarate by Alembic Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine fumarate (Quetiapine fumarate)

Snippet

SUPPL AP for QUETIAPINE FUMARATE (QUETIAPINE FUMARATE)